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        Introduction 
  Cell migration in response to chemotactic stimuli is a key aspect 
of many physiological and pathological processes (  Van Haastert 
and Devreotes, 2004  ). During migration, signals from the ex-
terior are relayed to the cell interior via surface receptors 
to initiate events necessary for effi  cient directional motility. 
The most extensively studied chemotactic receptors in the context 
of cell migration are the growth factor receptor tyrosine kinases 
(RTKs) studied in fi  broblasts and epithelial cells and G protein  –
  coupled receptors (GPCRs) extensively studied in leukocytes 
and   Dictyostelium discoideum   (  Van Haastert and Devreotes, 
2004  ). Regardless of which receptor system is involved in sens-
ing chemotactic stimuli, they signal via a conserved pathway 
that culminates in the activation and enhancement of Akt/PKB 
through phosphoinositide 3-kinase (PI3K) at the leading edge 
of migrating cells (  Merlot and Firtel, 2003  ;   Van Haastert and 
Devreotes, 2004  ). Once the Akt signal is adequately enhanced, 
cells   “  polarize  ”   and reposition their Golgi apparatus and micro-
tubule-organizing center (MTOC) in front of the nucleus and 
form the leading edge (  Etienne-Manneville and Hall, 2002  ; 
  Ridley et al., 2003  ) oriented toward the direction of the chemo-
tactic stimulus. 
 GIV  (G    -interacting vesicle-associated protein) was dis-
covered based on its ability to bind G     i3 (  Le-Niculescu et al., 
2005  ). Simultaneous work from other groups proposed distinct 
roles for GIV in endocytosis (  Simpson et al., 2005  ) and in regu-
lating cell migration via its interaction with Akt, actin, and PI4P 
(  Anai et al., 2005  ;   Enomoto et al., 2005  ). Of particular interest 
is the fact that GIV is localized at the crossroads of two major 
signaling pathways, as it is able to interact with     -subunits  of 
G proteins (  Le-Niculescu et al., 2005  ) and enhance PI3K-Akt 
activity upon RTK stimulation (  Anai et al., 2005  ). Although RTKs 
and G        -subunits are known to directly increase PI3K activity 
and subsequently activate Akt (  Stephens et al., 1997  ), the role of 
G     -subunits in this process has remained unclear. We set out to 
defi  ne the role of G     -subunits and the signifi  cance of its inter-
action with GIV during cell migration and to understand how 
G     -subunits and GIV link cell surface receptors to downstream 
signaling events. 
  In this paper, we show that G     i3 regulates GIV  ’  s func-
tions during cell migration. We provide mechanistic insights 
into how activation of the G protein dictates the formation of 
  D
uring migration, cells must couple direction sens-
ing to signal transduction and actin remodeling. 
We previously identiﬁ  ed GIV/Girdin as a G     i3 
binding partner. We demonstrate that in mammalian 
cells G     i3 controls the functions of GIV during cell 
migration. We ﬁ  nd that G     i3 preferentially localizes to 
the leading edge and that cells lacking G     i3 fail to 
polarize or migrate. A conformational change induced 
by association of GIV with G     i3 promotes Akt-mediated 
phosphorylation of GIV, resulting in its redistribution to 
the plasma membrane. Activation of G     i3 serves as a 
molecular switch that triggers dissociation of G           and 
GIV from the Gi3  –  GIV complex, thereby promoting cell 
migration by enhancing Akt signaling and actin re-
modeling. G     i3  –  GIV coupling is essential for cell migra-
tion during wound healing, macrophage chemotaxis, 
and tumor cell migration, indicating that the G     i3  –  GIV 
switch serves to link direction sensing from different fam-
ilies of chemotactic receptors to formation of the leading 
edge during cell migration.
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In quiescent cells far from the wound, G     i3 showed a predomi-
nant Golgi localization based on colocalization with a Golgi 
marker,      1-4 galactosyltransferase (     -GALT;   Fig. 1 A  , a  –  c), 
and was almost undetectable at the cell periphery marked by 
actin (  Fig. 1 A  , d  –  f). In contrast, migrating cells at the edge of 
the wound showed peripheral G     i3-stained puncta within lamelli-
podial extensions. Some of these puncta colocalized with actin 
at the leading edge (  Fig. 1 A  , g  –  j). Thus, G    i3  showed  different 
distributions depending on the migratory state of the cell. 
  Because GIV is a binding partner of the      -subunit of Gi 
and Gs and is important for cell migration, we asked if G    i3  or 
G     s is necessary for cell migration. We depleted G     i3 in HeLa 
cells using siRNA oligos (  Fig. 1 C  ) and measured the rates of 
wound closure. Depleting G    i3  (   95%) delayed wound heal-
ing (  Fig. 1 B  , g and h), whereas controls closed the wound as 
expected (  Fig. 1 B  , a and b). This impairment in migration was 
similar to that observed when GIV was depleted (    85%;   Fig. 1 B  , 
e and f). In contrast, depletion of G    s  (   90%) had no effect 
(  Fig. 1 B  , c and d). G     i3-depleted cells regained their ability to 
close the wound when G     i3 levels were replenished by ex-
pression of siRNA-resistant rat (rG     i3wt;   Fig. 1 B  , i  –  l). 
the leading edge in a chemotaxing cell by coupling direction 
sensing through cell surface receptors to Akt enhancement and 
actin remodeling via GIV. 
  Results 
  G    i3 is necessary for cell migration 
  Both GIV and G     i3 are localized on Golgi membranes and the 
plasma membrane (PM;   Stow et al., 1991  ;   Denker et al., 1996  ; 
  Enomoto et al., 2005  ;   Le-Niculescu et al., 2005  ). We reported 
previously that GIV is predominantly on vesicles near the Golgi 
during quiescence (  Le-Niculescu et al., 2005  ), and others re-
ported that during cell migration it accumulates at the leading 
edge where it interacts with Akt and participates in actin re-
modeling (  Enomoto et al., 2005  ). Because key participants in 
cell migration (GIV, PI3K, Akt, and actin;   Merlot and Firtel, 
2003  ;   Enomoto et al., 2005  ) are enriched at the leading edge, 
we asked if G     i3 behaves similarly. We subjected confl  uent 
monolayers of HeLa cells to scratch wounding to induce uni-
directional cell migration (  Kupfer et al., 1982  ) and examined the 
distribution of endogenous G     i3 by immunofl  uorescence (IF). 
  Figure 1.       G    i3 redistributes to the cell periph-
ery during cell migration and is necessary for cell 
migration.   (A) Distribution of G     i3 in quiescent 
(a  –  f) versus migrating (g –  j) HeLa cells after scratch 
wounding. In quiescent cells, endogenous G     i3 
colocalizes with      GalT in the Golgi (a  –  c) but not 
actin (d  –  f). In migrating cells, G     i3 is found in 
puncta that partially colocalize with actin at the 
leading edge (g  –  i). Arrows denote direction of 
migration. Boxed area in i is enlarged in j. HeLa 
cells were aldehyde ﬁ  xed 0 (left) and 8 (right) h 
after scratch wounding, as shown in the dia-
gram, and stained as indicated. Bars,10   μ  m. 
(B) Depletion of G     i3 (g and h) or GIV (e and f), 
but not G     s (c and d), impairs wound healing 
(compare with scrambled siRNA [scr siRNA] con-
trols; a and b). Repletion of hG     i3 by rat G     i3 
(i and j), but not vector alone (k and l), restores 
this defect. HeLa cells treated as indicated were 
subjected to scratch wounding and examined 
immediately after wounding (0 h) or 16 h later 
(  n   = 5). (C) Cell lysates from cells treated as in 
B were immunoblotted to assess the efﬁ  ciency 
of siRNA depletion of G    s (   90%), GIV (   85%), 
or G     i3 (    95%) and the expression of rG     i3. 
Several GIV bands are identiﬁ  ed that most likely 
are different posttranslationally modiﬁ  ed  forms 
of GIV because they are speciﬁ  cally depleted us-
ing GIV siRNA. (D) Comparative trajectories of 
G     i3-depleted cells versus those transfected with 
G     i3-YFP were followed by live cell imaging for 
8 h after wounding. Representative cells at the 
advancing edge of the wound (dashed line) were 
traced using a cell tracker application on videos 
obtained of transfected (solid squiggles) or un-
transfected (circles) cells through the YFP channel 
(b) or a simultaneously recorded DIC channel 
(a; Video 1, available at http://www.jcb.org/
cgi/content/full/jcb.200712066/DC1). (E) Bar 
graphs showing the distance covered by cells in 
D analyzed by the cell-tracker application (top 
graph) and the percent of untransfected G     i3-
depleted cells versus G     i3-depleted cells trans-
fected with rG     i3-YFP that displayed directional 
migration (bottom graph). Results are shown as 
mean   ±   SEM (  n   = 3).     383 G     I3 REGULATES GIV DURING MIGRATION   • Ghosh et al. 
  G    i3 is necessary for centrosome/MTOC 
repositioning during cell migration 
 Because  G    i3-depleted cells failed to undergo directional mi-
gration, we looked for defects in centrosome reorientation at the 
wound edge using HeLa cells stably expressing the centrosome 
marker Centrin1-GFP and quantifi  ed as described previously 
(  Fig. 3 B  ;   Kupfer et al., 1982  ;   Etienne-Manneville and Hall, 
2001  ). We observed that although     64% of control siRNA-
treated cells repositioned the centrosome in front of the nu-
cleus looking toward the wound, only     34% of G    i3-depleted 
cells (as was expected in the absence of polarization) achieved 
the same phenotype (  Fig. 3 C  ). GIV or G    s-depleted  cells 
were similar to controls. When rG     i3wt was introduced into 
G     i3-depleted cells, the defect in centrosome repositioning 
was reversed. Using deconvolution microscopy to visualize 
the plane of the centrosome, we found that both endogenous 
G    i3  ( Fig.  3  A ,  a – f)  and  endogenous  ( Fig.  3  A ,  j – l)  or  over-
expressed GIV (  Fig. 3 A  , g  –  i) localized at the centrosome with 
bona fi  de centrosomal proteins (pericentrin or     -tubulin)  in 
HeLa and Cos7 cells. Our fi  nding that both G     i3 and GIV 
localize to the centrosome region and only G     i3 is required 
for centrosomal repositioning suggests that the latter is a GIV-
independent function of G    i3. 
  G    i3 is required for enhancement of 
Akt signaling 
  Next, we asked whether G     i3 regulates GIV  ’  s functions in ac-
tivating Akt and remodeling actin after growth factor stimula-
tion, an approach which mimics scratch wound  –  induced Akt 
signaling in a more synchronized fashion (  Enomoto et al., 2005  ). 
When serum-starved HeLa cells were stimulated with insulin, 
Akt activity peaked at 5 min and was rapidly down-regulated 
within 15  –  30 min in controls (  Fig. 4 A  ). In G    i3-silenced  cells, 
the peak activation was reduced by     60% (  Fig. 4, A and B  ), 
which is similar to the effect observed after GIV depletion in 
HeLa (  Fig. 4 B  ) or HepG2 cells (  Anai et al., 2005  ). The effect 
was G    i  specifi  c because G     s depletion did not signifi  cantly 
affect Akt activation ( Fig. 4 A ) and was reversed when rG   i3wt 
was restored in G    i3  siRNA-treated  cells  (see Fig. 5 B). There-
fore, G     i3 links Akt activation and cell migration in a manner 
  Live cell imaging revealed that most (    75%) of the G    i3-
depleted cells displayed random oscillatory movements around 
a virtually motionless nucleus (  Fig. 1, D and E  ; and Video 1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200712066/DC1), 
resembling cells expressing a dominant-negative migration-
defective GIV mutant (  Enomoto et al., 2005  ). When siRNA-
resistant YFP-tagged rG    i3  (rG    i3-YFP) was introduced into 
Gi3-depleted cells,     75% of the transfected cells migrated to-
ward the wound (  Fig. 1 E  ). 
  G    i3 preferentially localizes to pseudopods 
at the leading edge of migrating cells 
  To study the dynamics of G     i3 localization after wounding, we 
observed HeLa cells expressing rG     i3-YFP by live cell imaging 
as they transitioned from quiescence to migration. Previously, 
we demonstrated that rG     i3-YFP localizes largely to the Golgi 
and behaves similarly to endogenous G     i3 (  Weiss et al., 2001  ). 
During migration, G     i3-YFP localized preferentially within 
pseudopods at the leading edge as manifest by the transient 
 “ blush ”  of fl  uorescent signal within these microdomains ( Fig. 2 A  
and Video 2, available at http://www.jcb.org/cgi/content/full/
jcb.200712066/DC1). This blush most likely refl  ects the tran-
sient localization of G     i3-stained puncta (  Fig. 1 A  , j) that are 
not resolved by the optical conditions used for live cell imaging 
(see Materials and methods). Because G     i3 is membrane an-
chored, membrane redundancy at the sites of pseudopod formation 
could lead to nonspecifi  c accumulation of membrane-anchored 
proteins (  Servant et al., 1999  ). However, myristoyl-palmitoyl  –
 modifi  ed YFP (mp-YFP), which has the same modifi  cations as 
G     i3-YFP and was previously characterized as a general mem-
brane marker (  Zacharias et al., 2002  ), showed patchy distribu-
tion along the entire PM and other membranous compartments 
without any preference for the leading edge during polarized 
migration (  Fig. 2 B   and Video 3). Accumulation of G    i3  was 
also observed within pseudopods at the leading edge using 
1,1 ’ -Dioctadecyl-3,3,3   ,3   -tetramethyllindodicarbocyanine  per-
chlorate (DiD) as an alternative membrane marker (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200712066/DC1; 
Servant et al., 1999). We conclude that G     i3, like its binding part-
ner GIV, is concentrated at the leading edge of a migrating cell. 
  Figure 2.       G    i3 localizes preferentially in 
pseudopods at the leading edge.   (A) Time-lapse 
images of a HeLa cell expressing G     i3-YFP mi-
grating into a freshly made wound visualized 
by live cell imaging. G     i3-YFP is preferentially 
localized within pseudopods at the leading 
edge (carats) during polarized migration. Time 
after wounding is expressed as hours:minutes:
seconds. Outline of the cell at the beginning 
of Video 2 (available at http://www.jcb
.org/cgi/content/full/jcb.200712066/DC1) 
is indicated with a dashed line. (B) Similar 
images of a HeLa cell expressing mp-YFP. 
Mp-YFP shows a patchy distribution over most 
of the PM (arrows) and other membranous 
compartments with no preferential localization 
to the leading edge (carats). The dashed line 
indicates the position of the cell at the begin-
ning of Video 3 (available at http://www.jcb
.org/cgi/content/full/jcb.200712066/DC1).     JCB • VOLUME 182 • NUMBER 2 • 2008  384
depleted cells using EGF as a ligand (  Enomoto et al., 2005  ). 
We conclude that G     i3 plays a major role in the organization of 
the actin cytoskeleton, most likely via its interaction with GIV, 
an established actin binding protein. 
  The distribution of GIV is altered in the 
absence of G    i3 
  We next investigated if silencing G     i3 leads to changes in the 
distribution of GIV. In quiescent cells treated with scr siRNA, 
we detected GIV on vesicles in and around the Golgi and scat-
tered throughout the cytoplasm (  Fig. 4 D  , a). Occasionally, GIV 
also colocalized with actin stress fi  bers (Fig. S4, available at 
http://www.jcb.org/cgi/content/full/jcb.200712066/DC1) as re-
ported by   Enomoto et al. (2005)   in fi  broblasts; however, this 
was an infrequent and inconsistent fi  nding in epithelial cells. 
We believe that this discrepancy in staining pattern is likely 
caused by the fact that epithelial cells express lower levels of 
GIV than mesenchymal cells. Depletion of G     i3 resulted in a 
more compact concentration of GIV staining in the Golgi re-
gion and reduced peripheral staining (  Fig. 4 D  , b). This pheno-
type was reversed when G     i3-depleted cells were replenished 
with rG     i3-YFP (  Fig. 4 D  , c  –  e). We conclude that G     i3 is nec-
essary for redistribution of GIV from the Golgi to more periph-
eral locations. 
  Activation of G    i3 is required for Akt 
enhancement and actin remodeling 
  Because heterotrimeric G protein signaling is regulated by the 
activation state of the      -subunit, we asked whether activation 
of G     i3 is required for its functions during cell migration. 
We transfected rG     i3Q204L and rG     i3G203A mutants, which 
behave like the GTP- and GDP-bound forms of G    i3,  respec-
tively (  Hermouet et al., 1991  ;   Coleman et al., 1994  ), into G    i3 
depleted cells and assessed their ability to reverse the effects of 
similar to that reported for GIV (  Anai et al., 2005  ). To distin-
guish whether G     i3 and GIV function in a common pathway 
or in independent parallel pathways mediating enhancement 
of Akt signaling, we investigated the effect of silencing both 
proteins. Silencing of G     i3 or GIV alone reduced Akt activa-
tion by     60 and 80%, respectively (  Fig. 4 B  ). When both were 
silenced (  Fig. 4 B  ), no signifi  cant difference was observed 
from GIV-depleted cells, indicating that the effect on Akt was 
not additive. The fact that depletion of G     i3 promoted weaker 
inhibition of Akt than GIV suggests that other Gi3-independent 
pathways might exist in which GIV is a common effector. Akt 
activation was also impaired when G     i3-depleted HeLa cells 
were stimulated with EGF (Fig. S2, available at http://www.jcb
.org/cgi/content/full/jcb.200712066/DC1), which implicates G    i3 
and GIV in a common pathway mediating Akt activation upon 
RTK stimulation. 
  G    i3 is necessary for remodeling of the 
actin cytoskeleton 
 Because PI3K-Akt signaling is associated with actin remodeling 
during cell migration, we next examined the organization of 
the actin cytoskeleton in the migration-defi  cient G    i3-depleted 
cells. Phalloidin staining for F-actin (fi  lamentous actin) revealed 
major differences in actin organization of G    i3-depleted  cells 
versus that of controls (  Fig. 4 C  , a and b): the G    i3-depleted 
cells were virtually unable to form long stress fi  bers and dis-
played a prominent bed of cortical actin but recovered their 
ability to form stress fi  bers when transfected with rG   i3wt-YFP 
(  Fig. 4 C  , c and d). We also investigated actin morphology in 
G     i3-depleted cells treated with insulin which induces actin re-
modeling (  Ridley et al., 1992  ) and found that actin remodeling 
and generation of stress fi  bers failed to occur upon insulin stim-
ulation (Fig. S3, available at http://www.jcb.org/cgi/content/
full/jcb.200712066/DC1). Similar results were obtained in GIV-
  Figure 3.       G    i3 and GIV localize at the centro-
some/MTOC and G    i3 is necessary for centro-
some repositioning.   (A) Deconvolved images 
through the centrosomes demonstrating the 
localization of G     i3 and GIV on centrosomes. 
HeLa and Cos7 cells were permeabilized, 
ﬁ  xed, and costained with a centrosome marker 
(     -tubulin or pericentrin) and G     i3 (a  –  f), GIV 
(j  –  l), or overexpressed V5-GIV (g  –  i). Bar,10   μ  m. 
(B) Schematic illustration (bottom) of the centro-
some repositioning assay performed on HeLa 
cells expressing GFP-Centrin1. Cells located 
at the edge of a wound are scored positive 
in which the centrosome (GFP-Centrin1, green) 
and Golgi (Man II, red) are positioned in front 
of the nucleus (DAPI, blue) within the 120  °   tri-
dent facing the direction of the wound (arrow). 
The white box indicates the area magniﬁ  ed 
below. Bar, 10   μ  m. (C) Bar graph showing the 
percentage of cells at the wound edge that 
achieved centrosome repositioning by 8 h 
after wounding. G     i3-depleted cells failed to 
reposition their centrosomes and transfection 
of G     i3wt restored this defect. GIV or G     s-
depleted cells were similar to controls (64%). 
Results (200  –  400 cells per experiment;   n   = 3) 
are shown as mean   ±   SEM. *, P   <   0.001; #, 
P   >   0.001 (compared with scr siRNA cells).     385 G     I3 REGULATES GIV DURING MIGRATION   • Ghosh et al. 
precipitated from brain lysates with GIV antibodies and that 
this interaction was abolished in the presence of GDP and 
AlF  4  
       ( Fig.  6  D ). 
  Because the active, but not the inactive, G     i3 mutant re-
versed the migration-defective phenotype of G    i3-depleted 
cells, activation of the G protein seems to be the key event lead-
ing to Akt enhancement during cell migration. However, in vitro 
binding studies showed that GIV preferentially binds to the 
  inactive G protein. Collectively, these observations support a 
working model whereby in vivo, the functional interaction be-
tween the G protein and GIV needs to be reversible as the 
G protein cycles between active and inactive states. 
  G    i3 promotes phosphorylation of GIV by 
Akt at S1416 
  In addition to being an enhancer of Akt activity, GIV is a sub-
strate for Akt at S1416, and this phosphorylation is critical for 
the function of GIV in cell migration (  Enomoto et al., 2005  ). 
Interestingly, S1416 lies within the G binding domain of GIV 
(  Le-Niculescu et al., 2005  ), raising the question of whether the 
G     i3  –  GIV interaction modulates ser/thr phosphorylation of 
GIV. We found that in G     i3-depleted cells GIV was poorly 
phosphorylated compared with controls (  Fig. 7 A  ). Repletion 
of G     i3 with rG     i3wt restored phosphorylation of GIV to con-
trol levels (  Fig. 7 A  ). To determine if the G    i3 – GIV  interaction 
enhanced or interfered with Akt mediated phosphorylation of 
G     i3 depletion. Transfection of either G     i3wt or the active 
rG     i3Q204L mutant restored cell migration (  Fig. 5 A  ), Akt ac-
tivation in response to insulin (  Fig. 5 B  ), formation of stress fi  -
bers (  Fig. 5 C  ), and distribution of GIV (  Fig. 5 D  ). Transfection 
of the inactive mutant rG     i3G203A had no effect on these pa-
rameters  ( Fig.  5, A – D ). 
  Next, we asked whether the interaction between G    i3  and 
GIV is activity dependent and found that the inactive GST-
G     i3G203A mutant consistently bound    10 – 15-fold  more 
GIV than the active G     i3Q204L mutant in in vitro binding as-
says using HeLa cell lysates or TnT (in vitro  –  translated) GIV 
( Fig.  6 A ). We  confi  rmed these results by preloading GST-G    i3 
with GDP alone or in the presence of AlF  4  
      , which mimics the 
active state (  Coleman et al., 1994  ). In the presence of GDP 
alone, GST-G     i3 bound     10  –  30% of the total GIV, and addi-
tion of AlF  4  
       virtually abolished the binding (  Fig. 6 B  ). In con-
trast, GST-G     s bound    100 – 300-fold  less  than  GST-G   i3 
(  Fig. 6 C  ), which is consistent with our fi  nding that G    s-depletion 
had no infl  uence on cell migration (  Fig. 1 B  ), Akt activation 
(  Fig. 4 A  ), or actin stress fi  ber formation (not depicted). These 
results demonstrate that GIV binding is specifi  c for G    i3  and 
is greatly reduced upon activation of the G protein. Because in-
active GDP-bound G     i3 interacts with both G         and GIV, 
we asked whether the      -subunit can interact with GIV when it 
is assembled into an intact heterotrimer. That this is the case is 
suggested by the fact that the G      subunit could be coimmuno-
  Figure 4.       G    i3 cooperates with GIV in Akt 
activation and actin remodeling and regulates 
the distribution of GIV.   (A) Depletion of G     i3 
but not G     s inhibits insulin-stimulated Akt ac-
tivation. HeLa cells treated as indicated were 
serum starved for 6 h and stimulated with 100 nM 
insulin. (Top) Lysates were separated by 
SDS-PAGE and immunoblotted for total (tAkt), 
phospho-Akt (pAkt), G     i3, G     s, and actin. 
(Bottom) Bar graph showing ratio of pAkt to 
tAkt in scr RNA controls versus cells depleted 
of G     i3 or G     s. (B) Simultaneous depletion of 
G     i3 and GIV does not have an additive ef-
fect on Akt signaling. (Top) HeLa cells treated 
as in A were immunoblotted for tAkt and pAkt 
5 min after insulin stimulation. (Bottom) Bar 
graph showing Akt activity in cells treated as 
in top expressed as percentage of the response 
in controls. Results are shown as mean   ±   SEM 
(  n   = 3). P values compared with scr-siRNA are 
indicated. (C) Depletion of G     i3 alters actin 
organization. Cells treated with scr siRNA (a) 
show stress ﬁ  bers whereas G     i3-depleted cells 
(b) are unable to form stress ﬁ  bers and show 
a prominent bed of cortical actin. The effects 
on actin in G     i3-depleted cells are reversed 
by transfecting rG     i3wt-YFP (d) but not vector 
alone (c). HeLa cells treated as indicated were 
stained with Phalloidin (red) and DAPI (blue). 
*, cells expressing rG     i3-YFP visualized with 
anti-GFP. Bar, 10   μ  m. (D) Distribution of GIV 
is less scattered and more concentrated in the 
Golgi (arrowheads) upon silencing G     i3 (com-
pare a and b). The scattered distribution is re-
stored upon transfecting rG     i3-YFP (c  –  e). HeLa 
cells were treated as indicated and stained for 
GIV (red), GFP (green), and DAPI (blue). *, cell 
expressing rG     i3-YFP visualized with anti-GFP 
mAb. Bar, 10   μ  m.     JCB • VOLUME 182 • NUMBER 2 • 2008  386
of GIV that might facilitate access of Akt to S1416. To investi-
gate whether such a change in confi  rmation takes place, we per-
formed limited proteolysis using increasing amounts of trypsin 
on immunopurifi  ed GIV ( Fig. 7 C ). GIV preincubated with GST, 
GST-G     i3wt, or GST-G     i3Q204L was relatively resistant to 
proteolysis, whereas GIV preincubated with G    i3G203A  was 
more susceptible to proteolysis, indicating a change in the con-
formation of GIV upon binding the inactive mutant. 
  We also asked whether phosphorylation of GIV at S1416 
affects its binding to G     i3 and found that this is not the case as 
wild-type, phosphorylation mimic (S1416D), or nonphosphory-
latable (S1416A) GIV all bound preferentially to the inactive 
GIV on S1416, we performed in vitro phosphorylation reactions 
with immunopurifi  ed GIV, GST-G     i3, and recombinant Akt. 
Because Akt phosphorylates immunopurifi  ed GIV at a single 
site, i.e., S1416 (  Enomoto et al., 2005  ), p-ser/thr antibody was 
used to estimate the amount of phosphorylation that occurred. 
We found that preincubation of GIV with GST-G    i3G203A, 
the inactive mutant that binds GIV most avidly, increased the 
phosphorylation of GIV     2.5 fold (  Fig. 7 B  , lane 6), whereas 
GST-G     i3Q204L and GST-G     i3wt were not signifi  cantly dif-
ferent (  Fig. 7 B  , lanes 4 and 5). We conclude that binding of 
G    i3 to GIV promotes phosphorylation of GIV at S1416 by Akt. 
We reasoned that this is likely via a change in the conformation 
  Figure 5.       Activation status of G    i3 determines its role in cell migration.   (A) Cell migratory behavior is restored by wild-type (a and b) and active (Q204L; 
c and d), but not the inactive (G203A; e and f), G     i3 mutant. (Top) HeLa cells expressing rG     i3wt, active, or inactive mutants were subjected to scratch 
wounding. (Bottom) Equal overexpression of G     i3 constructs was conﬁ  rmed by immunoblotting. In assays in which siRNA was followed by plasmid over-
expression, the efﬁ  ciency of transfection (    45  –  55%) was similar for wt, active, or inactive G     i3 constructs by IF (  n   = 3). (B) Insulin-stimulated Akt activation 
is restored by wt and active (Q204L) but not the inactive (G203A) G     i3 mutant. (Top) Assays were performed as in   Fig. 4 (A and B)   and samples were 
immunoblotted for tAkt and pAkt 5 min after stimulation. (Bottom) Bar graph showing percentage of Akt activation in cells treated as in top. Results are 
shown as mean   ±   SEM (  n   = 3). (C) Transfection of active (Q204L; a  –  c), but not inactive (G203A; d  –  f), mutant rG     i3-YFP restores normal actin organization 
(Phalloidin, red) in G     i3-depleted cells. *, cell expressing rG     i3-YFP visualized with anti-GFP (green). Bar, 10   μ  m. (D) Transfection of active (Q204L; a  –  c), 
but not inactive (G203A; d  –  f), rG     i3-YFP restores the normal (  Fig. 4D  , a) scattered peripheral and Golgi-associated (arrowheads) punctate distribution of 
GIV (red). *, cell expressing rG     i3-YFP visualized with anti-GFP (green). Bar, 10   μ  m.     387 G     I3 REGULATES GIV DURING MIGRATION   • Ghosh et al. 
(  Collins, 1987  ) into macrophages. GIV expression increased 
    18-fold at 48 h after TPA induction compared with undiffer-
entiated monocytes, whereas levels of G     i3 remained unchanged 
(  Fig. 8 A  ). We then asked if depletion of GIV would impair 
macrophage chemotaxis induced by activation the Gi-coupled 
fMLP receptor (  Allen et al., 1988  ). Macrophages were monitored 
in real time during the rapid phase (0  –  25 min) of chemotaxis 
toward a pipette tip continuously releasing fMLP (  Fig. 8 B  , 
top;   Chen et al., 2006  ). We found that depletion of either G    i3 
(  Fig. 8 B  , a  –  d) or GIV (  Fig. 8 B  , e and f) inhibited chemotaxis 
and impaired Akt activation (  Fig. 8 C  ). We conclude that G    i3 
and GIV are essential for Akt signaling during GPCR-stimulated 
macrophage chemotaxis. 
  We also investigated the expression pattern of G    i3  and 
GIV in cell lines derived from colon adenocarcinoma with vari-
able in vivo metastatic potential. GIV was expressed exclusively 
in cells with high metastatic potential (HCT116 and DLD1) and 
was virtually undetectable in those with poor metastatic poten-
tial (HT29p and Ls174T;   Fig. 8 D  ), whereas G     i3 and other 
regulatory proteins of the G protein pathway, i.e., GAIP (  Fig. 8 D  ), 
showed no such correlation. As in HeLa cells and macrophages, 
when highly metastatic DLD1 cells were treated with G    i3  or 
GIV siRNA, they demonstrated ineffi  cient migration in scratch 
wounding assays (  Fig. 8 E  ) and impaired Akt activation (  Fig. 8 F  ) 
compared with scr siRNA  –  treated cells. Because cell motility in 
scratch wound assays and Akt activity are validated predictors 
of the metastatic potential of tumor cells (  Raz, 1988  ;   Qiao et al., 
2007  ), DLD1 cells depleted of G     i3 or GIV might be expected 
to have poor metastatic potential compared with the parent cell 
line. Collectively, these results suggest a broader role for the 
G    i3 – GIV complex in migratory processes where direction sens-
ing through different chemotactic receptors uses this complex 
for Akt enhancement, actin remodeling, and cell migration. 
  Discussion 
  Summary and working model 
  This paper describes a novel mechanism by which G    i3  serves 
as a molecular switch that dictates the formation of the leading 
edge during cell migration via regulation of the distribution, 
phosphorylation, and functions of GIV. Without G    i3,  Akt  am-
plifi  cation downstream of both RTK and GPCR failed to occur, 
actin remodeling was inhibited, and cells failed to undergo po-
larized migration after scratch wounding. We also showed that 
G     i3 localizes preferentially within pseudopods at the leading 
edge and that activation of G     i3 is essential for migration. Col-
lectively, these results support a working model (  Fig. 9  ) of how 
the switch operates in few key steps: inactive Gi3 heterotrimer 
interacts avidly with GIV and induces a change in the confor-
mation of GIV. Upon a chemotactic stimulus (when Akt signal-
ing is initiated) the G     i3-bound conformation of GIV facilitates 
phosphorylation of GIV at a critical Ser residue that is necessary 
for its functions at the leading edge. Subsequently, activation 
of G     i3 triggers dissociation of the Gi3-GIV macromolecu-
lar complex releasing G        -subunits and GIV simultaneously. 
Released G         participates in localized PI3K-Akt activation (  Lilly 
and Devreotes, 1995  ), and released GIV amplifi  es and propagates 
G protein with similar strength (  Fig. 7 D   and Fig. S5, available 
at http://www.jcb.org/cgi/content/full/jcb.200712066/DC1). 
This indicates that the activation state of the G protein, and 
not phosphorylation of GIV at S1416, regulates the G    i3 – 
GIV interaction. 
  These results show that the G    i3 – GIV  interaction  facili-
tates phosphorylation of GIV by Akt. We propose that GIV 
bound to G     i3 adopts a conformation that brings Akt (bound to 
its C terminus) closer to S1416 in the G binding domain and 
thus facilitates its phosphorylation (  Fig. 7 E  ). 
  G    i3 and GIV are necessary for 
macrophage chemotaxis and cancer 
tumor cell migration 
  We also investigated the roles of G     i3 and GIV in other biologi-
cal processes that require Akt enhancement during cell migra-
tion, i.e., macrophage chemotaxis and cancer cell migration. 
Previous studies have established that Gi and GPCRs are impor-
tant for Akt activation during chemotaxis in macrophages and 
neutrophils (  Thelen, 2001  ) and that cancer cell lines, like HeLa, 
use RTKs for Akt activation during migration in scratch wound 
assays (  Tetreault et al., 2008  ). To fi  nd out how the G    i3 – GIV 
regulatory complex behaves during cell migration in macro-
phages, we analyzed THP1 human monocytes before and after 
tetradecanoyl-phorbol acetate (TPA)  –  induced differentiation 
  Figure 6.       Activation status of G    i3 regulates its interaction with GIV.  
(A and B) GIV binds preferentially to the inactive (Gai3G203A) form of 
Gai3. (A, Top) In vitro binding assays were performed using GST-G     i3 (wt 
or mutants) and either HeLa cell lysates (GIV (HeLa)) or in vitro  –  translated 
GIV (GIV (TnT)). Bead-bound fractions were separated by SDS-PAGE. Bound 
GIV was analyzed either by immunoblotting or autoradiography (TnT). 
(B, Top) In vitro binding assay performed as in A with GST-G     i3wt after GDP 
loading in the absence or presence of AlF  4   
      . (A and B, Bottom) Ponceau 
S-staining of PVDF membranes to show equal loading of GST proteins. 
(C) GIV preferentially binds to G     i3. In vitro binding assays were per-
formed as in B     with GST-G     i3 wt or G     s in the presence of GDP   ±   AlF  4   
       
loading to compare the relative binding of G     s and G     i3 to GIV. G     -subunits 
were used as a positive control. Bound GIV from HeLa cell lysates was vi-
sualized by immunoblotting (GIV (Low exp), low exposure; GIV (High exp), 
high exposure) and autoradiography (TnT), respectively. (D) GIV interacts 
with the inactive G                heterotrimer in vivo. GIV was immunoprecipitated 
from rat brain lysate in the absence (lanes 1  –  3) or presence (lanes 4  –  6) 
of GDP + AlF  4   
      , and immune complexes were probed for GIV and G      
subunits using anti  –  pan G     .     JCB • VOLUME 182 • NUMBER 2 • 2008  388
to the cell periphery. Mobilization of this internal pool of G    i3-
bound GIV to the cell periphery sets the stage for G protein 
activation and subsequent release of phosphorylated GIV. 
  G    i3, a state-dependent molecular switch 
for cell migration 
  Because the active Q204L, but not the inactive G203A, G    i3 
mutant reversed the phenotype of G     i3-depleted cells, activa-
tion of the G protein emerges as the key event in its functioning 
as a molecular switch. In the absence of G   i3 or after expression 
of inactive G     i3, Akt signaling does not occur (  Figs. 4 A and 5 B  ), 
indicating that the most signifi  cant and direct downstream con-
sequence of G     i3 activation is Akt enhancement. As a con-
sequence of this failure to enhance Akt signaling, phosphorylation 
of GIV on S1416, redistribution of GIV to the cell periphery, ac-
tin remodeling, and cell migration failed to occur (  Figs. 4 and 5  ). 
Because activation of G     i3 was necessary for migration, it 
came as a surprise that in in vitro binding assays the inactive 
G protein binds GIV     10  –  15-fold more than the active mutant. 
Collectively, our results suggest that the weaker interaction be-
tween the active G     i3 mutant and GIV is suffi  cient to facilitate 
targeting, phosphorylation, and the functions of GIV in vivo. 
Conversely, our fi  nding that a strong interaction between the 
inactive G protein and GIV has an overall inhibitory effect on 
GIV  ’  s functions indicates that reversible coupling is essential 
this Akt signaling (  Chen et al., 2003  ;   Postma et al., 2004  ). Am-
plifi  cation of cellular Akt activity via sequential coupling and 
uncoupling of G     i3 and GIV is likely to set up a positive feedback 
loop that mediates phosphorylation of further GIV molecules to 
remodel actin and form the leading edge. In this feedback loop, 
G proteins are presumably directly activated by GPCRs or in-
directly transactivated via RTKs. 
 G    i3 and GIV directly interact with each other and share 
dual localizations on the Golgi and the PM (  Enomoto et al., 
2005  ;   Le-Niculescu et al., 2005  ). Our results provide clues as to 
where in the cell this sequential G    i3 – GIV  molecular  coupling 
might occur. In quiescent cells, G     i3 was predominantly found 
on the Golgi where it partially colocalizes with GIV (  Fig. 1 A  ), 
and in migrating cells, G     i3 redistributes to the cell periphery and 
is concentrated in pseudopods at the leading edge (  Figs. 1 A 
and 2 A  ) where phosphorylated GIV accumulates during migra-
tion ( Enomoto et al., 2005 ). Additionally, we showed that deple-
tion of G     i3 leads to accumulation of GIV on Golgi membranes 
and impairs phosphorylation of GIV at S1416. Previously, 
phosphorylation of GIV at S1416 by Akt has been demonstrated 
to specifi  cally result in abolishing GIV  ’  s affi  nity toward PI4P 
(  Enomoto et al., 2005  ), a lipid known to be enriched in Golgi 
membranes. Based on these fi  ndings, we postulate that GIV 
phosphorylation at S1416, which is facilitated by the G   i3 – GIV 
interaction, mediates the redistribution of GIV from the Golgi 
  Figure 7.       G    i3 is necessary for phosphory-
lation of GIV by Akt.   (A) Phosphorylation of GIV 
is decreased upon depletion of G     i3 (G     i3 
siRNA) and restored upon transfecting rG     i3 
(G     i3 siRNA and rG     i3). GIV was immuno-
precipitated from HeLa cells treated as indicated 
and phosphorylation determined by immuno-
blotting with anti-pSer/Thr IgG. (B, top) G     i3 
binding to GIV promotes phosphorylation of 
GIV at S1416 by Akt. Immunoprecipitated GIV 
was preincubated in the presence or absence 
of     5   μ  g GST (lane 3), GST-G     i3wt (lane 4), 
G     i3 Q204L (lane 5), or G     i3 G203A (lane 6) 
and subsequently phosphorylated in vitro with 
recombinant Akt1, followed by SDS-PAGE. 
Phosphorylation was determined by immuno-
blotting with anti-pSer IgG. (B, bottom) Equal 
loading of preimmune or anti-GIV IgG and GST 
proteins was conﬁ  rmed by Ponceau S staining. 
(C) G     i3 binding to GIV increases its suscepti-
bility to trypsin-mediated proteo  lysis. Immuno-
precipitated GIV was incubated in the presence 
or absence of GST-G     i3 proteins as in B and 
digested with increasing concentrations of trypsin 
at 37  °  C for 8 min. The amount of uncleaved 
(trypsin resistant) GIV was determined by immuno-
blotting (inset) and displayed as percentage of 
starting amount (y axis) plotted against trypsin 
concentration (x axis). (D) GST-G     i3 interacts 
similarly with in vitro  –  translated GIV wild-type 
and phosphory  lation mimic (S1416D) or non-
phosphorylatable (S1416A) GIV mutants. Semi-
quantitative densitometry revealed that 14   ±   2, 
13   ±   1, and 14   ±   3% of wild-type, S1416A, 
and S1416D, respectively, bound to GST-G     i3 
(  n   = 5). (E) Schematic representation of how 
binding of G     i3 to GIV may mediate phosphory-
lation of GIV by bringing the C-terminal Akt bind-
ing site closer to the Akt phosphory  lation site.     389 G     I3 REGULATES GIV DURING MIGRATION   • Ghosh et al. 
GIV precedes its subsequent release from the complex. In a highly 
polarized chemotaxing cell, this is likely to occur on the PM 
at the leading edge where there is a concentration of ligand-
occupied receptors, activated Akt, and activated G    i3  ( Ridley  et  al., 
2003  ;   Van Haastert and Devreotes, 2004  ). Thus, the G protein 
molecular switch contributes to the spatial bias in accumulation 
of phosphorylated GIV that was previously demonstrated to 
occur selectively at the leading edge (  Enomoto et al., 2005  ). 
  G    i3 dictates formation of the leading 
edge by simultaneous release of G         and 
phosphorylated GIV 
  We found that G     i3 through its interaction with GIV is re-
quired for Akt enhancement and actin remodeling during scratch 
wound – induced migration in epithelial cells and for rapid chemo-
taxis in macrophages. However, in   D. discoideum   the  G   -subunit 
is dispensable and only G        -subunits are required for PI3K-Akt 
activation at the leading edge during GPCR-stimulated migra-
tion (  Lilly and Devreotes, 1995  ;   Brzostowski et al., 2004  ). It is 
noteworthy that there is only one G         subunit in   D. discoideum  
(  Lilly and Devreotes, 1995  ) and, to the best of our knowledge, 
there is no homologue of GIV. Thus, the differences between 
HeLa cells and   D. discoideum   may represent an acquired func-
tion of G     i in mammals, as the number of G proteins and their 
interacting partners expanded during evolution. 
for normal functioning of the switch. We conclude that the 
G    i3-GIV  association  constitutes  an   “ on ”   and   “ off ”   switch  that 
is regulated by cyclical G protein activation and is essential for 
phosphorylation, targeting, and subsequent release of GIV dur-
ing cell migration. 
  G    i3 regulates phosphorylation of GIV 
  We show here that the G     i3  –  GIV association is required for 
phosphorylation of GIV at S1416 by Akt. Phosphorylation of 
GIV at this site was previously demonstrated to play a critical 
role in cell migration, but the mechanism was unclear (  Enomoto 
et al., 2005  ). We provide evidence that GIV undergoes a change 
in conformation when bound to G     i3. It is noteworthy that 
the Akt binding site on GIV (extreme C terminus) is separated 
from S1416 (which lies within the G binding domain) by 
    300 aa (  Anai et al., 2005  ). We speculate that a major molec-
ular rearrangement occurs when GIV binds G     i3 to bring Akt 
bound to the carboxyl terminus closer to S1416 in the G bind-
ing domain and, thus, facilitates its phosphorylation. We also 
show that activation of G     i3 rather than phosphorylation of 
GIV is the key trigger for dissociation of GIV from the G    i –
 GIV  complex. 
  In the context of when these events take place, our results 
provide evidence that the cycling of G protein between active 
and inactive states ensures that phosphorylation of G    i3-bound 
  Figure 8.       The G    i3  –  GIV signaling complex 
is necessary for macrophage chemotaxis and 
tumor cell migration.   (A) GIV, but not G     i3, 
expression is induced     18-fold upon differ-
entiation of monocytes into macrophages. 
THP1 monocytes were treated with 5 nM TPA 
or DMSO carrier, and the expression of G     i3 
and GIV was followed by immunoblotting over 
68 h. (B) Depletion of G     i3 or GIV impairs 
macrophage chemotaxis. (Top) Schematic il-
lustration of the chemotaxis assay in which 
macrophages migrate toward a pipette tip, 
continuously releasing fMLP to maintain a gra-
dient. The dashed line denotes the edge of the 
monolayer just before the application of the 
chemotactic gradient. (Bottom) THP1-derived 
macrophages treated with scr (a and b), G     i3 
(c and d), or GIV (e and f) siRNA were imaged at 
the end of a fMLP chemotaxis assay. Arrow de-
notes direction of chemotaxis. Bars: (a, c, and e) 
250   μ  m; (b, d, and f) 50   μ  m. (C) Immuno-
blotting performed on lysates harvested at 
the end of the chemotaxis assay (shown in B) 
demonstrating that depletion of G     i3 or GIV 
impairs Akt activation (pAkt) in THP1-derived 
macrophages. (D) GIV is expressed in colon 
cancer cell lines with high (HCT-116, DLD1) 
but not low (HT-29p, LS-174T) in vivo meta-
static potential. G     i3 and GAIP (used as a 
control) expression are similar in all cell lines. 
(E) Depletion of G     i3 or GIV impairs wound 
healing in highly metastatic colon cancer cells. 
DLD1 cells treated with scr (a and b), G     i3 
(c and d), or GIV (e and f) siRNA were moni-
tored at 0 and 36 h after scratch-wounding. 
Bars, 1 mm. (F) Depletion of G     i3 (left) or GIV 
(right) impairs Akt activation (pAkt) in highly 
metastatic DLD1 colon cancer cells. Immuno-
blots were performed on lysates harvested at 
the end of a wounding assay.     JCB • VOLUME 182 • NUMBER 2 • 2008  390
G     i3 accounts for a major part of Akt signaling (    60% of the 
peak Akt activity upon insulin/EGF stimulation) via regula-
tion of GIV, indicating that although G       -subunits  initiate 
Akt signaling through activation of PI3K (  Lilly and Devreotes, 
1995  ), accumulation of simultaneously released phosphory-
lated GIV is essential for localized enhancement of Akt at the 
leading edge via the PI3K  –  Akt pathway (  Xiao et al., 1997  ; 
  Anai et al., 2005  ;   Enomoto et al., 2005  ). Thus, our work pro-
vides mechanistic insights into how activation of G    i3  links 
direction sensing to GIV-mediated PI3K  –  Akt enhancement and 
actin remodeling at the leading edge. 
  G    i3 is required for centrosome 
repositioning during migration 
  We found that both G     i3 and GIV are localized on centrosomes 
and are necessary for polarized migration, whereas G    i3,  but 
not GIV, is required for repositioning the MTOC/centrosome. 
In contrast, GIV is required for polarized migration but is not 
essential for centrosome repositioning. This is in keeping with 
the fact that asymmetrical extension of lamellipodia and centro-
some repositioning are not necessarily coupled during polarized 
migration of epithelial cells (  Euteneuer and Schliwa, 1992  ). 
Our results suggest a distinct hierarchy within the G    i3 – GIV 
regulatory complex, in which G     i3 regulates additional steps 
during cell migration besides those performed by GIV. The role 
of centrosomal GIV could be to nucleate microtubule tracks to 
the leading edge because, like other members of the Hook fam-
ily, GIV can bind to microtubules (  Simpson et al., 2005  ). 
  Direction sensing via different chemotactic 
receptors converge upon G    i3 and GIV 
 GIV has been implicated in RTK-stimulated migration  ( Enomoto 
et al., 2005  ), and Gi is well known to be important for GPCR-
stimulated chemotaxis (  Thelen, 2001  ). Our results now demonstrate 
that activation of G     i3 is required during scratch wound  – 
induced migration where cross talk between GPCRs and RTKs 
are known to mediate chemotactic movements (  Shan et al., 
2006  ;   Yin et al., 2007  ). Similarly, we have shown that upon di-
rect stimulation with RTK ligands (insulin and EGF), activation 
of G     i3 is required to elicit a full response in terms of Akt acti-
vation, suggesting that prominent transactivation of G proteins 
takes place. Additionally, we provide evidence supporting the 
necessity for GIV during GPCR-stimulated Akt signaling or 
chemotaxis. Although indirect stimulation of some RTKs by 
GPCR – G  protein – dependent  intermediates  is  well  established 
(  Luttrell et al., 1999  ), there is little mechanistic insight into how 
RTK stimulation might directly signal via G proteins to activate 
Akt (  Waters et al., 2004  ;   Dhanasekaran, 2006  ). In this paper, we 
show that in epithelial cells during wound healing, chemotaxing 
macrophages, and tumor cells, the state-dependent interaction 
between G     i3 and GIV is essential, and upon depletion of ei-
ther of these proteins the critical step of amplifi  cation of Akt 
signaling is abrogated. 
  We conclude that regardless of how the chemotactic sig-
nal is propagated from the cell surface to initiate Akt signaling, 
the common theme is the requirement of G     i3 activation and 
GIV to promote cell migration. Although we cannot rule out 
  We found that during cell migration, G    i3  preferentially 
localizes to the leading edge where enhancement of Akt sig-
naling occurs (  Merlot and Firtel, 2003  ). It is well established 
that to form a leading edge and migrate, cells must display bi-
phasic Akt activation in response to a chemotactic stimulus in 
that a brief early phase of generalized Akt activation is fol-
lowed by an enhanced and prolonged phase. The second phase 
of enhancement creates a steep PI3K-Akt signaling gradient 
that is restricted to the stretch of PM destined to form the lead-
ing edge (  Chen et al., 2003  ;   Postma et al., 2004  ). However, the 
uniformity of distribution of chemotactic receptors (RTKs and 
GPCRs;   Servant et al., 1999  ;   Bailly et al., 2000)   and shallow 
anterior – posterior  gradient  of  G     subunits (  Jin et al., 2000  ) 
fails to account for this steep signaling gradient (  Xiao et al., 
1997  ;   Janetopoulos et al., 2001  ;   Ueda et al., 2001  ). Our obser-
vation of preferential accumulation of G     i3 together with the 
localization of phospho-GIV at the leading edge (  Enomoto 
et al., 2005  ) sets the stage for sequential signal amplifi  cation 
by placing the G     -subunit in the immediate vicinity of the ligand-
occupied receptors that can activate G proteins. Activation of 
  Figure 9.       Working model.   (1) GIV preferentially and avidly binds to in-
active GDP-bound G     i3. Interaction with G     i3 induces a change in confor-
mation of GIV (dotted arrow). In a quiescent cell, this step is likely to occur 
predominantly on vesicles near the Golgi where G     i3 and GIV were previ-
ously shown to colocalize. (2) Upon a chemotactic stimulus, Akt signaling 
is initiated and results in phosphorylation of GIV at S1416. This critical 
phosphorylation step is facilitated by the favorable conformation of GIV 
induced by direct interaction with G     i3. Phosphorylation at S1416 was 
previously shown to be necessary for GIV  ’  s functions during cell migration 
(  Enomoto et al., 2005  ). (3) Upon phosphorylation, GIV continues to pref-
erentially and avidly bind to G     i3; however, it selectively loses its afﬁ  nity 
for PI4P (  Enomoto et al., 2005  ), a phosphoinositide that is enriched in the 
Golgi, and redistributes from Golgi membranes to the peripheral actin 
bed near the PM. (4) Activation of G     i3 occurs, likely downstream of 
ligand occupied receptors, and is the key event that mediates simultaneous 
dissociation of G           and GIV from the Gi3  –  GIV complexes. (5) Released 
G           activates PI3K-dependent Akt signaling (  Lilly and Devreotes, 1995  ). 
(6) Released phospho-GIV enhances the initial Akt signaling (  Anai et al., 
2005  ), remodels actin, and promotes migration. (7) This second phase of 
Akt signal enhancement is critical for formation of the leading edge dur-
ing polarized cell migration. Cyclical activation and inactivation of G     i 
in vivo thus contributes to progressive Akt enhancement, which promotes 
further cycles of GIV phosphorylation (8 and 2), redistribution of phosphor-
ylated GIV from Golgi to PM/actin (3), and subsequent release from the 
Gi3  –  GIV complexes upon activation of G     i3 (4). This contributes to the 
previously observed accumulation of phosphorylated GIV at the leading 
edge (  Enomoto et al., 2005  ) where GIV rapidly remodels actin to gener-
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sion was performed 8  –  10 h after siRNA transfection, and cells were ana-
lyzed after     38  –  40 h. In those assays where siRNA was followed by 
plasmid overexpression, the efﬁ  ciency of transfection was     45  –  55%. 
  Lysates used as a source for GIV were prepared by resuspending 
the cells in lysis buffer (20 mM Hepes, pH 7.2, 5 mM Mg-acetate, 125 mM 
K-acetate, 0.4% Triton X-100, and 1 mM DTT), supplemented with phos-
phatase (Sigma-Aldrich) and protease inhibitor cocktails (Roche), passed 
through a 28G needle at 4  °  C, and cleared at 10,000   g   for 5 min before 
use in subsequent experiments. 
  Cell migration assays 
  Monolayer cell cultures (    100% conﬂ  uent) were wounded with a 1-ml 
sterile pipette tip creating a 1-mm wound, as previously described (  Enomoto 
et al., 2005  ), and monitored by phase contrast or time-lapse video micros-
copy over the succeeding 12  –  16 h. For rapid chemotaxis assays, THP1 
cells were differentiated using 5 nM TPA. Upon reaching conﬂ  uency, half 
of the plate was scraped, and cells were monitored by phase-contrast 
microscopy during the succeeding 25 min as they migrated toward 
a steady chemoattractant gradient generated by releasing 100   μ  M 
fMLP (Sigma-Aldrich) from a micropipette tip placed on the opposite side 
of the plate. 
  Live-cell imaging 
  HeLa cells grown in chambered coverglass (Thermo Fisher Scientiﬁ  c) were 
scratch wounded to induce migration. Media was changed to Liebovitz 
L-15 supplemented with 2.5 mM Hepes, 4.5 g/liter glucose, and 100 mM 
sodium pyruvate as cells were placed on the stage of an inverted micro-
scope (Axiovert 200M; Carl Zeiss, Inc.) equilibrated at 37  °  C (Incubator 
XL-3 [Carl Zeiss, Inc.] Heating Unit and TempControl 37  –  2 Digital). Images 
of many ﬁ  elds of cells along the wound edge were taken at 40  ×   magniﬁ  ca-
tion (Plan Neoﬂ  uar objective [Carl Zeiss, Inc.], 1.3 NA) in DIC and YFP 
channels every 10 min for 8 h using an XYZ moving stage (MS2000; Ap-
plied Scientiﬁ  c Instrumentation) and charge-coupled device camera (Micro-
Max 512 BFT; Princeton Instruments) with Slidebook 4.1 software (Intelligent 
Imaging Innovations, Inc.). Image processing was done using ImageJ soft-
ware (National Institutes of Health). 
  In vitro binding 
  15  –  20   μ  g of puriﬁ  ed GST fusion proteins or 30   μ  g GST alone were immo-
bilized on glutathione Sepharose beads and resuspended in binding buffer 
(50 mM Tris-HCl, pH 7.4, 100 mM NaCl, 0.4% [vol/vol] NP-40, 10 mM 
MgCl  2  , 5 mM EDTA, 2 mM DTT, and protease inhibitor cocktail) containing 
    250   μ  g cell lysate. In some experiments, [ 
35  S]met (GE Healthcare)-
labeled GIV was prepared using the TnT Quick Coupled Transcription/
Translation System (Promega). Binding was performed overnight at 4  °  C 
with constant tumbling, and the beads were washed (4.3 mM Na  2  HPO  4  , 
1.4 mM KH  2  PO  4  , pH 7.4, 137 mM NaCl, 2.7 mM KCl, 0.1% [vol/vol] 
Tween 20, 10 mM MgCl  2  , 5 mM EDTA, and 2 mM DTT) and boiled in 
sample buffer for SDS-PAGE. In the experiments using nucleotide loading, 
G proteins were preincubated with 30   μ  M GDP or 30   μ  M GDP, 30   μ  M 
AlCl  3  , and 10 mM NaF in binding buffer for 90 min at room temperature 
before binding, and the washing buffer was supplemented with GDP or 
GDP, AlCl  3  , and NaF as during binding. Bound proteins were either immuno-
blotted or exposed for autoradiography. 
  Immunoprecipitation 
  Cell lysates (    1  –  2 mg of protein) were incubated overnight at 4  °  C with 
2   μ  l of preimmune or anti-GIV serum in PBS. Protein A agarose beads (Invi-
trogen) were added and incubated at 4  °  C for an additional 90 min. Beads 
were either resuspended and boiled in SDS sample buffer or used for in vitro 
phosphorylation or trypsinization assays. 
  In vitro phosphorylation and limited proteolysis with trypsin 
  GIV was immunoprecipitated from Cos7 lysates, subdivided into equal 
aliquots, and preincubated with equal amounts (5   μ  g) of puriﬁ  ed GST or 
GST-G     i3 constructs (wt, Q204L, and G203A) for 4 h at 4  °  C. Phosphory-
lation was performed in 20 mM Hepes, pH 7.5, 5 mM MgCl  2  , 20 mM 
     -glycerophosphate, 1 mM EDTA, 0.1%      -mercaptoethanol, phosphatase, 
and protease inhibitor cocktail for 90 min at 30  °  C. The reaction was initi-
ated by adding 50   μ  M ATP and 1,000 mU human recombinant activated 
Akt1 (EMD) and terminated by boiling in SDS sample buffer. Trypsin diges-
tion was performed as described previously (  Ghosh and Kornfeld, 2003  ). 
  IF 
  All the steps for IF were performed at room temperature as described pre-
viously (  Zheng et al., 2004  ). In brief, cells were ﬁ  xed with 3% PFA for 
that different biochemical events may occur depending on whether 
GPCRs or RTKs are activated, it is tempting to speculate that 
molecular coupling between G     i3 and GIV could serve as a 
novel platform for receptor cross talk and that together they 
could be the long-sought missing link between chemotactic re-
ceptors and signal amplifi  cation. 
  Materials and methods 
  Reagents and antibodies 
  Unless otherwise indicated, all reagents were of analytical grade and 
obtained from Sigma-Aldrich, and cell culture media were purchased 
from Invitrogen. Antibodies against the coiled-coil region of GIV were 
raised in rabbits and puriﬁ  ed as previously described (  Le-Niculescu et al., 
2005  ). Antibodies against G     s and G     i3 were obtained from EMD, and 
pan G      (M-14) and G     i3 used for immunoblotting were purchased from 
Santa Cruz Biotechnology, Inc. Rabbit IgG against phospho-Akt (serine 
473) was purchased from Cell Signaling Technology, and mAb against 
total Akt was purchased from BD Biosciences. MAbs against actin, 
     -tubulin, and rabbit IgG against phosphoserine were purchased from 
Sigma-Aldrich. Anti  –  mouse and anti  –  rabbit Alexa 594  –   and Alexa 488  –
  coupled goat secondary antibodies for IF, phalloidin-Texas Red, and anti-V5 
were purchased from Invitrogen. Rabbit antiserum against mannosidase II 
(ManII) was prepared as described previously (  Velasco et al., 1993  ). 
Goat anti  –  rabbit and goat anti  –  mouse Alexa Fluor 680 or IRDye 800 
F(ab  ’  )2 were obtained from LI-COR Biosciences, and DiD was obtained 
from Invitrogen. The autoimmune human serum against pericentrin (5051) 
and mAb against      GALT were gifts from S.J. Doxsey (University of Mas-
sachusetts, Worcester, MA) and E.G. Berger (University of Zurich, Zurich, 
Switzerland), respectively. 
  Plasmids, mutagenesis, and protein expression 
  Full-length GIV cloned into a pcDNA 3.1 vector was provided by M. Takahashi 
(  Enomoto et al., 2005  ). GIV S1416A and S1416D mutants were gen-
erated according to the manufacturer  ’  s instructions (QuickChange II; 
Stratagene) and conﬁ  rmed by sequencing. Primer sequences are avail-
able upon request. Wild-type rat G     i3 cDNA, G     i3 (Q204L), and G     i3 
(G203A) mutants, obtained from A. Spiegel (National Institutes of Health, 
Bethesda, MD), were subcloned into pcDNA 3.1 (Invitrogen) or pGEX-4T-1 
(GE Healthcare) vectors. Cloning of G     i3 tagged with YFP at the C termi-
nus was described previously (  Weiss et al., 2001  ). The plasmid encoding 
the mpYFP was a gift from R. Tsien (University of California, San Diego, 
La Jolla, CA). cDNA encoding the human G     s long (L) and short (S) splicing 
variants were obtained from Guthrie cDNA Resource Center(  Zheng et al., 
2004  ) and were subcloned into pGEX-KG vector. 
  Plasmids encoding GST-G     i3 wild type and mutants (Q204L or 
G203A) or GST-G     s fusion proteins were used to express these proteins in 
  Escherichia coli   strain BL21(DE3) (Invitrogen), and protein expression was 
induced overnight at 25  °  C by IPTG. Pelleted bacteria from 1 liter of culture 
were resuspended in 10 ml of lysis buffer (Buffer A), sonicated four times 
for 20 s with 1 min between cycles, and centrifuged at 12,000   g   at 4  °  C 
for 20 min to remove insoluble material. Solubilized proteins were afﬁ  nity 
puriﬁ  ed using glutathione Sepharose 4B beads (GE Healthcare). Proteins 
were eluted, dialyzed overnight against PBS, and stored at      80  °  C. 
  Cell culture, transfection, and lysis 
  Cos7, HeLa, and HeLa-C1 cells expressing Centrin1-GFP (  Piel et al., 2000  ) 
were grown at 37  °  C in DME supplemented with 10% FBS, 100 U/ml peni-
cillin, 100   μ  g/ml streptomycin, 1%   L-  glutamine, and 5% CO  2  . HCT116, 
HT29p, LS174T, and DLD1 cell lines were maintained as speciﬁ  ed  by 
American Type Culture Collection. THP1 human monocytic cells were ob-
tained from C.K. Glass (University of California, San Diego, La Jolla, CA) 
and cultured in RPMI-1640 supplemented with   L-  glutamine and 10% heat-
inactivated FBS (  Collins, 1987  ). For all assays involving serum starvation, 
serum concentration was reduced to 0.2% for 6 h. 
  Plasmid DNA and siRNA transfection of HeLa, DLD1, or THP-1 (  Kilpatrick 
et al., 2006  ) cells was performed using FUGENE 6 (Roche) or Oligofectamine 
(Invitrogen) according to the manufacturers  ’   protocols. For G     i3-YFP and 
mpYFP transfection, GeneJuice (EMD) was used. Oligos against human 
G     i3 were obtained from Santa Cruz Biotechnology, Inc., and oligos 
against human GIV (  Enomoto et al., 2005  ), G     s long, and G     s short (  Zheng 
et al., 2004  ;   Enomoto et al., 2005  ) were custom designed by Thermo 
Fisher Scientiﬁ  c. When reversal of phenotype was attempted, overexpres-JCB • VOLUME 182 • NUMBER 2 • 2008  392
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30 min, permeabilized with 0.2% Triton X-100 for 45 min, and incubated 
for 1 h with primary and secondary antibodies. Antibody dilutions 
were as follows: afﬁ  nity puriﬁ  ed anti-GIV, 1:10; anti-G     i3 (EMD), 1:30; 
anti-V5 (Invitrogen), 1:200; anti-ManII, 1:500; anti-pericentrin, 1:1,000; 
anti  –       -tubulin (Sigma-Aldrich), 1:500; anti-     GALT, 1:20; Phalloidin-Texas 
Red, 1:1,000; secondary Alexa-conjugated antibodies, 1:500; and 
DAPI, 1:2,000 (Invitrogen). To visualize endogenous GIV or G     i3, cells 
were permeabilized with 0.05% (weight/vol) saponin and 0.2 mg/ml 
BSA in PBS for 1 min before ﬁ  xation. Images were acquired with a micro-
scope (Axioimager M1; Carl Zeiss, Inc.) using a 100  ×   aperture (Plan 
Neoﬂ  uar; 1.3 NA), camera (Orca ER; Hamamatsu Photonics), and Open-
lab software (Improvision). For the centrosome repositioning assay, HeLa-
C1 monolayers were scratch wounded, and 8  –  10 h after wounding the 
number of cells with centrosomal (GFP-centrin) and Golgi (ManII) posi-
tioning within the 120  °   sector facing the wound were counted (  Fig. 2  ; 
  Kupfer et al., 1982  ;   Etienne-Manneville and Hall, 2001  ;   Grande-Garcia 
et al., 2007  ). 
  For centrosomal localization studies, wide-ﬁ  eld microscopy was 
performed using the 100  ×   1.3 N.A Neoﬂ   uor oil immersion objective 
lenses on an inverted microscope (IX-70 DeltaVision Restoration; Olym-
pus). The microscope was equipped with DAPI (360/40 excitation, 
457/50 emission), FITC (490/20 excitation, 528/38 emission), and 
TRITC (555/28 excitation, 617/73 emission) band pass ﬁ   lter sets, a 
motorized stage (FCS2; Bioptechs), and a charge-coupled device cam-
era (Photometrics CH350; Hamamatsu Photonics). Optical sections were 
collected at 0.2-  μ  m intervals along the apical  –  basal axis. Applied Preci-
sion software (DeltaVision) was used to deconvolve z-section series of 
images. All individual images were processed using Image J software 
and assembled for presentation using Photoshop and Illustrator software 
(both Adobe). 
  Immunoblotting 
  Proteins samples were separated on 10% SDS-PAGE and transferred to 
PVDF membranes (Millipore). Membranes were blocked with PBS supple-
mented with 5% nonfat milk and then incubated sequentially with primary 
and secondary antibodies. Infrared imaging with two-color detection and 
quantiﬁ  cation of Western blots was performed according to the manufac-
turer  ’  s protocols using an Odyssey imaging system (Li-Cor Biosciences). 
When anti-phosphoprotein antibodies (anti-pSer/Thr or anti-pAkt) were 
used, nonfat milk was replaced by BSA throughout the process. The dilu-
tion of the primary antibodies was as follows: anti-GIV serum, 1:500; anti-
G     i3, 1:200; anti-G     s, 1:250; anti-actin, 1:2,000; anti-Akt total, 1:250; 
anti-pAkt, 1:250; anti-pSer, 1:250; anti-G     , 1:200. 
  Statistical analysis 
  Experiments were repeated at least three times and results are expressed 
as mean   ±   SEM. Statistical signiﬁ  cance between various conditions was 
assessed with Student  ’  s   t   test. P   <   0.001 was considered signiﬁ  cant. 
  Online supplemental material 
  Fig. S1 shows validation that G     i3 is preferentially localized within 
pseudopods at the leading edge during cell migration using DiD as a 
PM marker. Fig. S2 shows that depletion of G     i3 impairs EGF-stimulated 
Akt activation. Fig. S3 shows that insulin-stimulated actin remodeling is 
inhibited in G     i3-depleted cells. Fig. S4 shows that GIV is occasionally 
distributed along actin stress ﬁ  bers in epithelial cells. Fig. S5 shows that ac-
tivation status of the G protein, and not phosphorylation of GIV at S1416, 
regulates the G     i3  –  GIV interaction. Video 1 shows that HeLa cells ex-
pressing rG     i3-YFP demonstrate directional migration toward the wound 
whereas G     i3-depleted cells show random motility. Video 2 shows that 
G     i3-YFP preferentially localizes within pseudopods at the leading edge 
of a migrating HeLa cell. Video 3 shows that mp-YFP is distributed along 
the PM during polarized cell migration, with no preference for the lead-
ing edge. Online supplemental material is available at http://www.jcb
.org/cgi/content/full/jcb.200712066/DC1. 
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